Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-invasive tests for alcohol-associated liver disease
Mads Israelsen, Wiramon Rungratanawanich, Maja Thiele, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1390-1407
Closed Access | Times Cited: 10

Showing 10 citing articles:

Steatotic liver disease
Mads Israelsen, Sven Francque, Emmanuel Tsochatzis, et al.
The Lancet (2024) Vol. 404, Iss. 10464, pp. 1761-1778
Closed Access | Times Cited: 28
Metabolic Dysfunction and Alcohol-related Liver Disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Juan Pablo Arab, Luis Antonio Díaz, Jürgen Rehm, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 21
Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study
Federica Tavaglione, Maral Amangurbanova, Alexander H. Yang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 8
Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States
Pojsakorn Danpanichkul, Kwanjit Duangsonk, Markos Kalligeros, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 4
Reporting discrepancy of alcohol intake affecting estimated prevalence of MetALD and ALD
Aleksander Krag, Nikolaj Torp, Zobair M. Younossi, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 1
Changes in the epidemiological trends of primary liver cancer in the Asia–Pacific region
Pojsakorn Danpanichkul, Kanokphong Suparan, Banthoon Sukphutanan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder
Paola Zuluaga, Daniel Fuster, Rafael Blanes, et al.
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 7, pp. 1313-1321
Open Access | Times Cited: 2
Unique urine and serum metabolomic signature in patients with excessive alcohol use: An exploratory study
Zhihong Yang, Hui Gao, Jing Ma, et al.
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 8, pp. 1519-1528
Closed Access | Times Cited: 2
From detection to intervention, optimizing care for patients with alcohol use disorder and advanced hepatic fibrosis
Paola Zuluaga, Suthat Liangpunsakul
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 12, pp. 2253-2255
Open Access | Times Cited: 1
Increased mortality from alcohol use disorder, alcohol‐associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021
Pojsakorn Danpanichkul, Kwanjit Duangsonk, Elaine Tham, et al.
Alcohol Clinical and Experimental Research (2024)
Open Access
Page 1

Scroll to top